Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Psoriasis | D011565 | EFO_0000676 | L40 | — | — | — | — | 1 | 1 |
Atopic dermatitis | D003876 | EFO_0000274 | L20 | — | — | — | — | 1 | 1 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | — | — | 1 | 1 |
Dermatitis | D003872 | HP_0011123 | L30.9 | — | — | — | — | 1 | 1 |
Drug common name | Edodekin alfa |
INN | edodekin alfa |
Description | Edodekin alfa is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | interleukins: interleukin-12 analogues and derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2109059 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 31Z82G8ME1 (ChemIDplus, GSRS) |